Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen premedication for pain reduction during vital pulp therapy in MIH-affected mandibular first permanent molars in children
IRCT20250308064976N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ibuprofen in carious lesion and molar incisor hypomineralisation (MIH), sponsored by Isfahan University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
ibuprofen
03
Conditions
carious lesionmolar incisor hypomineralisation (MIH)
Beyond the preview
Go deeper on IRCT20250308064976N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250308064976N1.